drugs
publication date
Strategy
Gottlieb's Last Day: FDA Commissioner Returns to Conservative Think Tank
The part-time role will reportedly occupy only about six hours of Gottlieb's time each month, leaving quite a bit of...
Innovation
FDA Moves to Curb Insulin Price Hikes as Pressure on Manufacturers Mounts
Insulin manufacturers have long been criticized for raising their list prices year after year. Now the FDA aims to make...
Strategy
Gottlieb Confident in FDA's Direction as His Departure Nears
The decision to leave the agency did not come easily, but the commissioner said he feels good about where things...
How Much Difference Will Eli Lilly's Half-Price Insulin Make?
Between 2009 and 2017 the wholesale price of a single vial of Humalog, the Eli Lilly and Co.-manufactured insulin, nearly...
Finance
Drug Pricing Proposals Put Pharma at Greater Financial Risk
Efforts at the state and federal level to reduce prescription drug prices pose a financial risk for pharmaceutical companies, according...
Finance
HHS Proposal Could Kill PBM Rebates: Some Pleased, Others Concerned
The proposal would end safe-harbor protections for the rebates drug manufacturers pay to PBMs and add safe-harbor protections for drug...
Finance
Q4 Earnings Strong for Celgene Ahead of Bristol-Myers Squibb Deal
The Summit, New Jersey-based biotech giant released its Q4 2018 earnings report weeks after Bristol-Myers Squibb announced a $74 billion...
Finance
Secretive 'Rebate Trap' Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Drug companies routinely make hidden pacts with middlemen that effectively block patients from getting cheaper generic medicines.
Clinical Care
Healthcare Marketing Expenditures Increase $12.2 Billion Over Past Two Decades
Pharmaceutical company marketing to healthcare professionals accounted for the largest portion of spending, set at $20.3 billion in 2016.
Strategy
Civica Rx Adds 12 Health Systems as Founding Members
The alliance, which was formed last year by seven health systems and three philanthropic organizations, aims to tamp down drug...
Clinical Care
When Medicine Makes Patients Sicker
The FDA is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a...